Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Jan;56(1):711-721.
doi: 10.1007/s12035-018-1122-9. Epub 2018 May 23.

The Fragile X Protein and Genome Function

Affiliations
Review

The Fragile X Protein and Genome Function

Thomas C Dockendorff et al. Mol Neurobiol. 2019 Jan.

Abstract

The fragile X syndrome (FXS) arises from loss of expression or function of the FMR1 gene and is one of the most common monogenic forms of intellectual disability and autism. During the past two decades of FXS research, the fragile X mental retardation protein (FMRP) has been primarily characterized as a cytoplasmic RNA binding protein that facilitates transport of select RNA substrates through neural projections and regulation of translation within synaptic compartments, with the protein products of such mRNAs then modulating cognitive functions. However, the presence of a small fraction of FMRP in the nucleus has long been recognized. Accordingly, recent studies have uncovered several mechanisms or pathways by which FMRP influences nuclear gene expression and genome function. Some of these pathways appear to be independent of the classical role for FMRP as a regulator of translation and point to novel functions, including the possibility that FMRP directly participates in the DNA damage response and in the maintenance of genome stability. In this review, we highlight these advances and discuss how these new findings could contribute to our understanding of FMRP in brain development and function, the neural pathology of fragile X syndrome, and perhaps impact of future therapeutic considerations.

Keywords: Chromatin; DNA damage repair; FMRP; Fragile X mental retardation; Genome stability.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Hum Mol Genet. 1999 Dec;8(13):2557-66 - PubMed
    1. Cell. 2001 Nov 16;107(4):477-87 - PubMed
    1. Cell. 2001 Nov 16;107(4):489-99 - PubMed
    1. Proc Natl Acad Sci U S A. 2002 May 28;99(11):7746-50 - PubMed
    1. Genes Dev. 2002 Oct 1;16(19):2491-6 - PubMed

Substances

LinkOut - more resources